08 August 2024

Scientists unravel how the BCG vaccine leads to the destruction of bladder cancer cells

Using zebrafish “Avatars”, an animal model developed by the Cancer Development and Innate Immune Evasion lab at the Champalimaud Foundation (CF), led by Rita Fior, Mayra Martínez-López – a former PhD student at the lab now working at the Universidad de las Américas in Quito, Ecuador – and colleagues studied the initial steps of the Bacillus Calmette-Guérin (BCG) vaccine’s action on bladder cancer cells.

International Congress on Neurodegenerative Diseases

Co-organised by Fundación CIEN, Fundación Reina Sofía, and the Champalimaud Foundation, this scientific congress aims to bring advances in research in the fight against Alzheimer's and other neurodegenerative diseases to the public, and above all, to raise awareness to advance the search for global solutions and responses due to their social consequences.

18 July 2024

Breast cancer: first scientifically validated guidelines on the usefulness of the imaging exam known as FDG PET/CT

Experts from two international nuclear medicine societies (EANM and SNMMI) have joined those from important societies of various other medical specialities involved in the care of breast cancer patients – including oncology, surgery, radio-oncology and breast imaging – to draw up a set of recommendations, based on scientific evidence, on the correct utilisation, in breast cancer, of a medical imaging exam. The exam in question has been used for several years and involves radioactive substances, in this case a glucose analogue called fluorodeoxyglucose (FDG).

Maria Domingos

16 July 2024

Claes Dohlman, "father" of modern corneal surgery and 2022 António Champalimaud Vision Award, has died

Claes Dohlman, emeritus professor of Ophthalmology and former chair of the Department of Ophthalmology at Mass Eye and Ear and Harvard Medical School, died on July 14, 2024. He was 101.

Often recognized as the “father” of modern corneal science, Dohlman shared the 2022 António Champalimaud Vision Award with Gerrit Melles, from the Netherlands Institute for Innovative Ocular Surgery in Rotterdam.

11 Jul. 2024

2 Postdoctoral Fellows at Tissue Immunity Lab

Research
Application Starts: 11 Jul. 2024

Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a 2 Postdocs to join our team at the Champalimaud Research Program. 

The selected candidate will:

The position

09 July 2024

Four Researchers in Portugal Elected as EMBO Members

Now, Megan Carey from the Champalimaud Foundation (CF), Mónica Sousa from the Instituto de Investigação e Inovação em Saúde (i3S), Ricardo Henriques from the Instituto Gulbenkian de Ciência (IGC), and Rui Oliveira from IGC and the Instituto Universitário de Ciências Psicológicas Sociais e da Vida (ISPA), become EMBO Mem

Innovative High-throughput Approaches to Understanding and Combating Cancer

Host

Adriana Sánchez Danés, Principal Investigator, Champalimaud Research


Venue

Seminar room


Abstract

To overcome the complexities of cancer and pave a path towards a cure, the McManus Lab is developing innovative approaches that consider both the genetic drivers of the disease and its interactions within the cellular environment. Join Dr. McManus to explore new technologies and methods to combat this multifaceted complex human disease.

02 July 2024

What am I looking at? A Galactic Splatter

The images created during the daily scientific and medical endeavours at the Champalimaud Foundation can be as beautiful and compelling as any work of art. To the untrained eye, these images might also appear baffling, but, if you know what you’re looking at, they may just reveal information that can spark discoveries, contribute to the improvement of patient quality of life and maybe even alter our understanding of reality.

Manuel Jacinto

Subscribe to Researchers
Loading
Please wait...